Foreword from supplement editors - Focus on Cardiometabolic matters

Cardiometabolic diseases are a group of common but often preventable conditions and are a leading cause of morbidity and mortality globally. Advances in screening and investigation to identify predisposing and contributing risk factors pave the way for preventive management. The emergence of new therapies in diabetes, hypercholesterolaemia and kidney disease has improved our armamentarium in the fight against cardiometabolic disease.

This supplement discusses ways to reduce cardiovascular risk in people with chronic kidney disease or type 1 diabetes, highlights the need to ‘look beyond the liver’ in those with metabolic dysfunction-associated fatty liver disease and outlines the important role of GPs in identifying and managing people with familial hypercholesterolaemia. It also considers the importance of exercise compared with testosterone and incretin-based weight loss therapy for improving cardiometabolic health and reviews how to mitigate the potential cardiovascular risk in the transgender population.

We hope that this supplement, written by diverse expert authors, will provide GPs and other healthcare professionals with a clinically relevant update to enhance the cardiometabolic health of their patients.